June 10 Financial Quick Takes: Vivo raises $1.3B for ninth fund; plus Prevail, Dermavant, Akero set terms for IPOs

Vivo has at least $1.3B for next fund
Vivo Capital has raised $1.3 billion toward its ninth fund from

Read the full 185 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE